Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: Validation of a gastrointestinal symptom questionnaire

Journal of Clinical Rheumatology

Volumn 11, Issue 4, 2005, Pages 194-204

  Brunner, Hermine I ^a   Johnson, Anne L ^b   Barron, Andrea C ^b   Passo, Murray H ^b   Griffin, Thomas A ^b   Graham, T Brent ^b   Lovell, Daniel J ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

Children; GI symptoms; GISSK; HRQOL; JIA; JRA; QoL

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DISABILITY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG USE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL SYMPTOM SCALE FOR KIDS; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PEDIATRIC QUALITY OF LIFE GENERIC CORE SCALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOLOGY MODULE; SCHOOL CHILD; VISUAL ANALOG SCALE;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL DISEASES; HEALTH STATUS; HUMANS; MALE; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 23644462441     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000173616.81928.44     Document Type: Article

References (28)

1. Petty R, Cassidy J, eds. Textbook of Pediatric Rheumatology. 4th ed. Philadelphia: WB Saunders Co; 2001.
2. Brunner HI, Kim KN, Ballinger SH, et al. Medication choices in juvenile rheumatoid arthritis. J Clin Rheumatol. 2001;7:295-300.
3. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340:1888-1899.
4. Keenan GF, Giannini EH, Athreya BH. Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis. J Rheumatol. 1995;22:1149-1151.
5. Wolfe F, Kong SX, Watson DJ. Gastrointestinal symptoms and health related quality of life in patients with arthritis. J Rheumatol. 2000;27:1373-1378.
6. Singh G, Athreya BH, Fries JF, et al. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37:1761-1769.
7. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126-139.
8. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800-812.
9. Varni JW, Seid M, Smith Knight T, et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Genetic Core Scales and Rheumatology Module. Arthritis Rheum. 2002;46:714-725.
10. Feldman BM, Grundland B, McCullough L, et al. Distinction of quality of life, health related quality of life, and health status in children referred for rheumatologic care. J Rheumatol. 2000;27:226-233.
11. Brunner H, Maker D, Grundland B, et al. Preference-based measurement of health related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKD): utilities by standard gamble do not correlate with preferences measured by other techniques. Med Decis Making. 2003;23:314-322.
12. Dempster H, Porepa M, Young N, et al. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum. 2001;44:1768-1774.
13. Fleiss J. Statistical Methods of Rates and Proportions. New York: Wiley Inc; 1981.
14. Steinfeld S, Bjorke PA. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib. Rheumatology (Oxford). 2002;41(suppl 1):23-27; discussion 35-42.
15. Hollingworth P. The use of non-steroidal anti-inflammatory drugs in paediatric rheumatic diseases. Br J Rheumatol. 1993;32:73-77.
16. Dowd JE, Cimaz R, Fink CW. Nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children. Arthritis Rheum. 1995;38:1225-1231.
17. Ashorn M, Verronen P, Ruuska T, et al. Upper endoscopic findings in children with active juvenile chronic arthritis. Acta Paediatr. 2003;92:558-561.
18. Thiessen PN. Recurrent abdominal pain. Pediatr Rev. 2002;23:39-46.
19. Ravelli A, Gerloni V, Corona F, et al. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. Clin Exp Rheumatol. 1998;16:181-183.
20. Foeldvari I, Burgos-Vargas R, Thon A, et al. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis. J Rheumatol. 2002;29:1079-1083.
21. Singsen BH, Goldbach-Mansky R. Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders. Rheum Dis Clin North Am. 1997;23:811-840.
22. Lisse JR, Perlman M, Johansson G, et al. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann Intern Med. 2003;139: 539-546.
23. Hunt RH, Barkun AN, Baron D, et al. Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents. Can J Gastroenterol. 2002; 16:231-240.
24. Bombardier C. An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol. 2002;89:3D-9D.
25. Drossman DA. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med. 1999;107:41S-50S.
26. Heymann-Monnikes I, Arnold R, Florin I, et al. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol. 2000;95:981-994.
27. Drossman DA, Whitehead WE, Toner BB, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol. 2000;95:974-980.
28. Rasch G. An item analysis which takes individual differences into account. Br J Math Stat Psychol. 1966;19:49-57.